Jennifer currently works at Janssen as a research scientist specializing in patient outcomes and treatment effectiveness. Before joining Janssen, she was at Takeda, leading an observational research analytics team in support of company products via use of RWD. She was also the principal statistician for a Phase IIIb Vaccine trial and a Phase IV biologics safety trial. Prior to Takeda, she was an assistant professor at Harvard Medical School with numerous publications in observational studies.